We transfer a screening system from Academic Sinica. With the tech, we can screen for a series of specific compounds, which have the ability to transfer white adipocyte to brown adipocyte or to increase white adipocyte. Our primary goal is to produce weight losing drug. Due to the long process of drug development, we decided to start with tackling the trade barrier and the safety problem of ractopamine. Currently, we can extract our target compound from chinese herbal medicine. In animal test, we can observe white adipose tissue transfered to brown adipose tissue, following by decreasing of body fat. We have contact with US, Canadian and French Chamber of Commerce and preparing large scale animal clinical experiments aboard. We are looking forward to replace ractopamine as a safe and efficiency product. Because obesity is an important risk factor for type 2 diabetes, high blood pressure and hyperlipidemia in human or pet. In the near future, we will use single entity compound paten...
We transfer a screening system from Academic Sinica. With the tech, we can screen for a series of specific compounds, which have the ability to transfer white adipocyte to brown adipocyte or to increase white adipocyte. Our primary goal is to produce weight losing drug. Due to the long process of drug development, we decided to start with tackling the trade barrier and the safety problem of ractopamine. Currently, we can extract our target compound from chinese herbal medicine. In animal test, we can observe white adipose tissue transfered to brown adipose tissue, following by decreasing of body fat. We have contact with US, Canadian and French Chamber of Commerce and preparing large scale animal clinical experiments aboard. We are looking forward to replace ractopamine as a safe and efficiency product. Because obesity is an important risk factor for type 2 diabetes, high blood pressure and hyperlipidemia in human or pet. In the near future, we will use single entity compound patented by US that inhibit obesity and obesity mediated metabolic syndrome as a basis and may also combine with extract from Salvia miltiorrhiza (Chinese herbs) to serve as health food, animal medicine, microneedle patch and for translational medicine application. The last stage is entering human clinical test for drug development and health care product to prevent fat related disease.
More information